logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5209.produseast1
Leishmaniasis | Journal Article / Review | MSF Science Portal
Journal Article
|Review

Leishmaniasis

Burza S, Croft SL, Boelaert M
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Leishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0·7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.

Subject Area

neglected tropical diseasesleishmaniasis

Languages

English
DOI
10.1016/S0140-6736(18)31204-2
Published Date
01 Sep 2018
PubMed ID
30126638
Journal
Lancet
Volume | Issue | Pages
Volume 392, Issue 10151, Pages 951-970
Issue Date
2018-09-01
Dimensions Badge